|Videos|February 2, 2022
Managing MS With Wellness Approaches During COVID-19: Kathy Zackowski, PhD, OTR
Author(s)Kathy Zackowski, PhD, OTR
The senior director of patient management, care, and rehabilitation at the National Multiple Sclerosis Society discussed the importance and flexibility of wellness approaches for patients with MS during the pandemic. [WATCH TIME: 4 minutes]
Advertisement
WATCH TIME: 4 minutes
"It makes it even more important to stay on top of treatments for mental health issues. Depression is what first comes to me, but anxiety is another common problem. The idea of integrating different wellness strategies could address some of those issues. COVID-19 has just elevated the need for that kind of thing, by the fact that it’s forced us to change our lifestyles so much."
Throughout the COVID-19 pandemic, patients with multiple sclerosis (MS) have been faced with possible changes in the management of their disease, mainly by adapting to a more virtual style of care. For these uncompromised patients, their fears of the pandemic may be exacerbated, and social isolation may be more of a possibility. Some experts, including Kathy Zackowski, MD, OTR , believe the need for integrative wellness approaches and an increased focus on overall health have never been bigger.
Zackowski, senior director, patient management, care, and rehabilitation, National Multiple Sclerosis Society, published a 2020 paper that promoted the wellness of patients through health behaviors amid the pandemic. She and her colleagues documented evidence-based physical, nutritional, and emotional wellness recommendations that are not only relevant to people with MS, but to other rehabilitation populations who are adversely affected by the decreased physical and social activity, uncertainty, economic hardship, and other lifestyle restrictions common during that time.
NeurologyLive® sat down with Zackowski to get her thoughts on effective wellness approaches adopted in the pandemic, the need to continue to reenforce the importance of overall health, and whether some practices may stick around for the long run.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
NeurologyLive® Friday 5 — September 12, 2025
5